Could universal pharmacare reduce excessive drug price hikes in Canada? Eric Hoskins, former Ontario Minister of Health, will chair a federal government advisory council to implement a national pharmacare plan. Hoskins is pictured here with federal Minister of Health Ginette Petitpas Taylor.
(THE CANADIAN PRESS/Justin Tang)
The cost of a life-saving drug in Canada is rising by 3,000 per cent. A national pharmacare plan could bring order to this chaotic world of Canadian drug prices.
Leave your medicines in their box when you go abroad, and check if you need a doctor’s letter.
Before travelling, plan ahead in case you need to pack medicines for sleep, diarrhoea, malaria, pain or anxiety.
People have to pass road tests – so should self-driving cars.
There's a common, popular and well-studied method to ensure new technologies are safe and effective for public use – even if researchers don't fully understand how they work.
Moving a robot is like manipulating a molecule.
Researchers use an algorithm designed to help robots move to figure out what's possible when designing new molecules in a promising class of pharmaceuticals.
We’re a nation of medication hoarders, and that can be dangerous.
If you look into your kitchen or bathroom cabinet, chances are you'd find some unused medicine, much of it expired. Here's what to do with it.
People with type 2 diabetes are putting their health at risk by not taking their medication because of side effects.
Prescribing a drug for a condition it hasn't been tested for may sound reckless, but off-label prescribing has a useful function in medicine.
Medication usage has gone through the roof in the last decade.
Canada spends more per capita on prescription drugs than most other OECD countries.
Canada is the only nation with a broad public health system lacking universal coverage for pharmaceuticals. Despite fears that pharmacare would be too costly, it could end up saving Canadians money.
People with cystic fibrosis, Australia’s most common inherited condition, have thick mucus, including on the lungs.
Wider availability of the cystic fibrosis drug Kalydeco since May 1, 2017 means younger patients can now access it.
Ababil Wings SS / shutterstock
We have barely begun to tap into the pharmaceutical potential of the most diverse animals of all.
Advertisements for complementary medicines don’t always reflect what’s in the bottle.
Consumers can't always be confident claims for complementary medicines stack up. Here's how to foster truth in advertising.
Focusing on price instead of drug information could put patients at risk.
Every day, more discount pharmacy stores and chains are opening and assaulting health-care consumers with the “we are cheaper” message.
The well-used drug clomipramine could target tumour cells and leave normal cells healthy – if scientists could get enough evidence for it.
All the guidelines recommend paracetamol for pain relief despite the lack of evidence for the drug's effectiveness.
The yellow in Van Gogh’s Starry Night looks like symptoms of foxglove extract overdose.
Many suspect Van Gogh suffered from foxglove extract overdose due to the yellow halos in his paintings and his portrait of his physician holding the plant.
What the doctor ordered?
Pills by Shutterstock
How new medicines subsidised by individual nations in the EU is a complicated business.
Look for a warning on the box before you attempt to crush or chew tablets, or cut capsules open.
Some people are incapable of swallowing tablets because of physical or psychological reasons. What should they do when the doctor prescribes a drug that comes in tablet form?
Insulin, which is used for controlling diabetes and has been in the market for 30 years, was the first biologic.
Biologics are widely accepted as the most effective way of treating certain diseases. They have become the fastest-growing class of therapeutic compounds, with about 300 now available for human use.
Only recently has conversation about access to new drugs been moving to acknowledging the need for a community debate about affordability as well.
Decisions about public subsidies for high-cost drugs are naturally quite complex. And while patients have increasingly been given a voice in the process, the views of the wider community have generally…